November 1, 2021 | Targeted Therapies in Oncology

Evolving Biomarkers in Pancreatic Cancer: Path to Prediction

November 14, 2021

Clinical Articles

According to Andrew S. Barbas, MD, of Duke Health, the scarcity of testing that can provide accurate results in patients with pancreatic cancer contributes to diagnoses in the advanced stages of the disease and consequently to poor prognoses.

Frontline Acalabrutinib Improves Quality-Adjusted Survival in CLL

November 03, 2021

Clinical Articles

Patients treated with acalabrutinib monotherapy had a significantly longer mean duration of time spent without toxicity compared with those treated with chlorambucil plus obinutuzumab in the phase 3 ELEVATE-TN trial.